# Telomir Pharmaceuticals, Inc.: Form S-1/A, filed Dec 14, 2023

- Company: [Telomir Pharmaceuticals, Inc.](/companies/telo.md) (CIK 1971532)
- Form: S-1/A
- Filed: 2023-12-14
- Accepted by EDGAR: Dec 14, 2023, 17:09 ET
- Period: not reported
- Accession: 0001493152-23-044902
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1971532/000149315223044902/forms-1a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1971532/000149315223044902/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1971532/000149315223044902/forms-1a.htm

Filed Dec 14, 2023.
Source: SEC EDGAR, the filing index for accession 0001493152-23-044902. Last ingested by Listed: Nov 6, 2026, 17:47 ET. No prices; not investment advice.
